ZC3H13-mediated m6A stabilization of CCND1 promotes malignant progression and is associated with poor anti-PD-1 response in HNSCC.
- DOI
- 10.1002/ctm2.70750
- Published
- 2026 Aug
- Container
- Clinical and translational medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/ctm2.70750,
title = {ZC3H13-mediated m6A stabilization of CCND1 promotes malignant progression and is associated with poor anti-PD-1 response in HNSCC.},
author = {Chen W and Li Y and Chen S and Zhang C and Liu Z and Sun K and Li Y and Yang C and Lei W and Li K},
year = {2026},
journal = {Clinical and translational medicine},
doi = {10.1002/ctm2.70750},
url = {https://doi.org/10.1002/ctm2.70750}
}RIS
TY - JOUR TI - ZC3H13-mediated m6A stabilization of CCND1 promotes malignant progression and is associated with poor anti-PD-1 response in HNSCC. AU - Chen W AU - Li Y AU - Chen S AU - Zhang C AU - Liu Z AU - Sun K AU - Li Y AU - Yang C AU - Lei W AU - Li K PY - 2026 JO - Clinical and translational medicine DO - 10.1002/ctm2.70750 UR - https://doi.org/10.1002/ctm2.70750 ER -
APA
W, C., Y, L., S, C., C, Z., Z, L., K, S., Y, L., C, Y., W, L., & K, L. (2026). ZC3H13-mediated m6A stabilization of CCND1 promotes malignant progression and is associated with poor anti-PD-1 response in HNSCC.. Clinical and translational medicine. https://doi.org/10.1002/ctm2.70750
Source records
- pubmed · retrieved 2026-09-25T05:53:57.766Z